Suppr超能文献

对乙酰氨基酚在离体灌注大鼠肾脏中的肾小管效应。

Tubular effects of acetaminophen in the isolated perfused rat kidney.

作者信息

Trumper L, Monasterolo L A, Ochoa E, Elias M M

机构信息

Farmacologia, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Republic of Argentina.

出版信息

Arch Toxicol. 1995;69(4):248-52. doi: 10.1007/s002040050166.

Abstract

The effects of different acetaminophen (APAP) concentrations (1, 5 or 10 mM) on renal function were investigated in the isolated perfused rat kidney (IPK). APAP was added to the perfusion media as a single dose after a equilibration time and control periods. Changes in fractional excretion of sodium (FENa), water (FEH2O), glucose (FEglu) and in glomerular filtration rate (GFR) were measured. The lower concentration used only modified the FEH2O. APAP 10 mM induced an increment in FEH2O (72% higher than control preparation), FENa (79% higher than control preparation) and an elevation in glucose excretion (55% higher than control preparation), associated with a decrease in GFR (23% lower than control preparation). The influence of PGE2 on the effects of APAP was also investigated. PGE2 prevented the APAP-induced decrease in GFR and in glucose reabsorption, but did not change the pattern of sodium and water handling. The effects of another vasodilator, verapamil, on APAP-induced renal effects were also tested. Verapamil prevented the glomerular but not the tubular effects of APAP. Urinary APAP excretion data showed a similar availability of APAP to the tubular cells in all the groups. Our data suggest that APAP exerts a direct action in the IPK, affecting hemodynamic and tubular functions, and that the latter are not a consequence of hemodynamic alterations.

摘要

在离体灌注大鼠肾脏(IPK)中研究了不同对乙酰氨基酚(APAP)浓度(1、5或10 mM)对肾功能的影响。在平衡期和对照期后,将APAP作为单剂量添加到灌注介质中。测量了钠分数排泄(FENa)、水分数排泄(FEH2O)、葡萄糖分数排泄(FEglu)和肾小球滤过率(GFR)的变化。使用的较低浓度仅改变了FEH2O。10 mM的APAP导致FEH2O升高(比对照制剂高72%)、FENa升高(比对照制剂高79%)以及葡萄糖排泄增加(比对照制剂高55%),同时GFR降低(比对照制剂低23%)。还研究了前列腺素E2(PGE2)对APAP作用的影响。PGE2可防止APAP诱导的GFR降低和葡萄糖重吸收,但不改变钠和水的处理模式。还测试了另一种血管扩张剂维拉帕米对APAP诱导的肾脏效应的影响。维拉帕米可防止APAP的肾小球效应,但不能防止其肾小管效应。尿APAP排泄数据显示,所有组中APAP向肾小管细胞的可用性相似。我们的数据表明,APAP在IPK中发挥直接作用,影响血液动力学和肾小管功能,且后者并非血液动力学改变的结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验